Attorney General, DEA Director, Judge Under Federal Court Summons Over DEA Marijuana Policy
Despite the DEA’s policy, MMJ International is moving forward with the FDA on cannabis drug development for Huntington’s disease.
Despite the DEA’s policy, MMJ International is moving forward with the FDA on cannabis drug development for Huntington’s disease.